Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma

被引:1
|
作者
Xiong, Guohai [1 ,2 ]
Shan, Jinmei [1 ,2 ]
Chong, Qingguo [1 ,2 ]
Cui, Yueqing [1 ,2 ]
机构
[1] Yancheng Third Peoples Hosp, Dept Gynaecol, Yancheng 224008, Peoples R China
[2] Nanjing Med Univ, Dept Gynaecol, Yancheng Sch Clin Med, Yancheng 224008, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 08期
关键词
tertiary lymphoid structures; anti-tumor immunity; cervical cancer; prognosis; B-CELLS; IMMUNOTHERAPY; LANDSCAPE; REVEAL;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Cervical squamous carcinoma (CESC) is the main subtype of cervical cancer. Unfortunately, there are presently no effective treatment options for advanced and recurrent CESC. Tertiary lymphoid structures (TLSs) are clusters of lymphoid cells that resemble secondary lymphoid organs; nevertheless, there is no summary of the clinical importance of TLS in CESC. Methods: A large set of transcriptomic and single-cell RNA-sequencing (scRNA-seq) datasets were used to analyze the pattern of TLS and its immuno-correlations in CESC. Additionally, an independent in-house cohort was collected to validate the correlation between TLS and TME features. Results: In the current study, we found that the presence of TLS could predict better prognosis in CESC and was correlated with the activation of immunological signaling pathways and enrichment of immune cell subpopulations. In addition, TLS was associated with reduced proliferation activity in tumor cells, indicating the negative correlation between TLS and the degree of malignancy. Last but not least, in two independent immunotherapy cohorts, tumors with the presence of TLS were more sensitive to immunotherapy. Conclusion: Overall, TLS is related to an inflamed TME and identified immune-hot tumors, which could be an indicator for the identification of immunological features in CESC.
引用
收藏
页码:6898 / 6920
页数:23
相关论文
共 50 条
  • [41] Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma
    Ruiz-Torres, Daniel A.
    Bryan, Michael E.
    Hirayama, Shun
    Merkin, Ross D.
    Luciani, Evelyn
    Roberts, Thomas J.
    Patel, Manisha
    Park, Jong C.
    Wirth, Lori J.
    Sadow, Peter M.
    Sade-Feldman, Moshe
    Stott, Shannon L.
    Faden, Daniel L.
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [42] Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative Gastric Carcinoma
    Cheng, Na
    Li, Peng
    Cheng, Huanhuan
    Zhao, Xiaoxiao
    Dong, Min
    Zhang, Yiwang
    Zhao, Peizhen
    Chen, Jianning
    Shao, Chunkui
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity
    Yuli Li
    Guobo Shen
    Wen Nie
    Zhimian Li
    Yaxiong Sang
    Binglan Zhang
    Yuquan Wei
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1815 - 1823
  • [44] The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications
    Economopoulou, Panagiota
    Perisanidis, Christos
    Giotakis, Evaggelos I.
    Psyrri, Amanda
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (09)
  • [45] Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
    Wen, Xiang-mei
    Xu, Zi-jun
    Ma, Ji-chun
    Zhang, Min-jie
    Jin, Ye
    Lin, Jiang
    Qian, Jun
    Fang, Yuan-yuan
    Luo, Shu-yu
    Mao, Zhen-wei
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [46] Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer
    Meylan, Maxime
    Sautes-Fridman, Catherine
    Fridman, Wolf H.
    M S-MEDECINE SCIENCES, 2022, 38 (6-7): : 536 - 538
  • [47] Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma
    Nie, Ye
    Fan, Hanlu
    Li, Jianhui
    Lei, Xinjun
    Zhang, Tianchen
    Wang, Yanfang
    Mao, Zhenzhen
    Tao, Kaishan
    Song, Wenjie
    FASEB JOURNAL, 2022, 36 (11):
  • [48] Anti-tumor effects of telomelysin for head and neck squamous cell carcinoma
    Fujita, Kyoko
    Kimura, Machiko
    Kondo, Norio
    Sakakibara, Atsuko
    Sano, Daisuke
    Ishiguro, Yukari
    Tsukuda, Mamoru
    ONCOLOGY REPORTS, 2008, 20 (06) : 1363 - 1368
  • [49] The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma
    Ling, Yihong
    Zhong, Jian
    Weng, Zelin
    Lin, Guangrong
    Liu, Caixia
    Pan, Chuqing
    Yang, Hong
    Wei, Xiaolong
    Xie, Xiuying
    Wei, Xiaoli
    Zhang, Huizhong
    Wang, Geng
    Fu, Jianhua
    Wen, Jing
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (10):
  • [50] Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccine
    Wang, Huili
    Wang, Dongmei
    Li, Mengqiang
    Zhou, Chunxia
    Ma, Wenbo
    Su, Xiaosan
    Liu, Rongzhi
    Zhang, Shuren
    CANCER LETTERS, 2008, 268 (01) : 129 - 136